Pavmed Series Z Stock EBITDA
| PAVMZ Stock | USD 0.01 0.01 40.94% |
PAVmed Series Z fundamentals help investors to digest information that contributes to PAVmed Series' financial success or failures. It also enables traders to predict the movement of PAVmed Stock. The fundamental analysis module provides a way to measure PAVmed Series' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PAVmed Series stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -75.7 M | -72 M |
PAVmed | EBITDA |
PAVmed Series Z Company EBITDA Analysis
PAVmed Series' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current PAVmed Series EBITDA | (75.74 M) |
Most of PAVmed Series' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PAVmed Series Z is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PAVmed EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for PAVmed Series is extremely important. It helps to project a fair market value of PAVmed Stock properly, considering its historical fundamentals such as EBITDA. Since PAVmed Series' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PAVmed Series' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PAVmed Series' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
PAVmed Ebitda
According to the company disclosure, PAVmed Series Z reported earnings before interest,tax, depreciation and amortization of (75.74 Million). This is much lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is notably higher than that of the company.
PAVmed EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PAVmed Series' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PAVmed Series could also be used in its relative valuation, which is a method of valuing PAVmed Series by comparing valuation metrics of similar companies.PAVmed Series is currently under evaluation in ebitda category among its peers.
PAVmed Series Current Valuation Drivers
We derive many important indicators used in calculating different scores of PAVmed Series from analyzing PAVmed Series' financial statements. These drivers represent accounts that assess PAVmed Series' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PAVmed Series' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 30.8M | 21.4M | 100.6M | 42.8M | 29.8M | 57.7M | |
| Enterprise Value | 31.3M | 21.1M | 98.3M | 39.6M | 58.9M | 62.0M |
PAVmed Fundamentals
| Return On Equity | -13.58 | ||||
| Return On Asset | -0.8 | ||||
| Operating Margin | (13.98) % | ||||
| Number Of Shares Shorted | 73.53 K | ||||
| Revenue | 2.45 M | ||||
| EBITDA | (75.74 M) | ||||
| Net Income | (64.17 M) | ||||
| Total Debt | 48.73 M | ||||
| Book Value Per Share | (6.62) X | ||||
| Cash Flow From Operations | (52.04 M) | ||||
| Number Of Employees | 107 | ||||
| Beta | 0.69 | ||||
| Total Asset | 33.12 M | ||||
| Retained Earnings | (294.43 M) | ||||
| Working Capital | (29.68 M) | ||||
| Net Asset | 33.12 M |
About PAVmed Series Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PAVmed Series Z's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PAVmed Series using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PAVmed Series Z based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PAVmed Stock Analysis
When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.